Document is current

Article History

Received: 11 August 2023

Accepted: 25 September 2023

First Online: 6 October 2023

Declarations

:

: The proposed research is a multicentre pragmatic clinical study that includes humans and the handling of personal data. The entire study will be carried out in Sweden. Written, informed consent to participate will be obtained from all participants.Ethical approval and completion of the ethical approval for the proposed multicentre RCT were approved by the Swedish Ethical Review Authority on 2021–04-26 with Dnr 2021–01880 and on 2022–01-26 with Dnr 2021–07010-02. Further ethical approval was granted on 2022–03-26 with Dnr 2022–01503-02, on 2023–01-18 with Dnr 023–00021-02 and on 2023–07-20 with Dnr 2023–03925-02.Clinical trial registration was prospectively performed on 2021–06-04, with the ClinicalTrials.gov identifier NCT04915027.

: Not applicable—no identifying images or other personal or clinical details of participants are presented here or will be presented in reports of the trial results. The participant information materials and informed consent form are available from the corresponding author on request.

: As the corresponding author, author XH has created the paper version of the tool Rehabkompassen® and owns the registered trademark Rehabkompassen®. Author XH as the main applicant has obtained several Swedish national grants as stated in the Funding {4} above for the development and assessment of the tool.Together with other non-author colleagues, authors XH and OL have developed the tool from the paper version to the digital version and tested the tool in the feasibility study as the basis for this protocol. Authors XH and OL have no financial competing interests.Other authors declare that they have no competing interests.